Petrovax has announced positive results stemming from the Long-CoV-III-21 trial, which tested the efficacy of bovhyaluronidase azoximer (Longidaza) in patients with long-term COVID-19 pulmonary ...
Perhaps the biggest incentive for drug and device manufacturers to supplement clinical trials with AI digital twins is how it ...
A new study has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
Boundless Bio has decided against proceeding with testing of a treatment for solid tumors and colorectal cancer, and said that two of its top executives have decided to step down.
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program, shares findings on ...
Tony Newberne is a high-risk myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several nonprofits ...
Rochester General Hospital (RGH) is the first U.S. site of a groundbreaking pivotal clinical trial of the AquaPass, a system ...
Recently published research from the University of Oklahoma and the University of Tulsa shows that a new therapy for children ...
ACRO’s RBQM Working Group has announced the publication of its latest RBM/RBQM paper, Risk-Based Quality Management: A Case for Centralized Mon ...
More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...
The firm also has plans for tests beyond sepsis, including for cardiac events and other conditions that are commonly treated in acute care settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback